{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-020262","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.261836+00:00","generated_at":"2026-05-17T01:23:05.977423+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"INBS adds 33 new customer accounts in Q1 FY2026, up 50% YoY; total active accounts exceed 480","bullets":["Added 33 new customer accounts in fiscal Q1 ended Sept 30, 2025, a 50% increase YoY.","Total active accounts reached over 480; growth driven by maritime, transport, logistics, and new government sector.","91% of new accounts were first-time adopters; 9% expanded use within existing organizations.","Strong UK growth supported by distributor expansion across Europe and Middle East.","Global drug screening market projected at $17.1B by 2029, 15% CAGR, supporting INBS's expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-020262","json":"https://secwatch.observer/filing/0001493152-25-020262.json","markdown":"https://secwatch.observer/filing/0001493152-25-020262.md","text":"https://secwatch.observer/filing/0001493152-25-020262.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225020262/0001493152-25-020262-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225020262/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:23:05.977423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}